MARKETS
PERPS
LIVE
78
PRO
MORE
Cash
Portfolio
Log in
Sign up
Trending
Elections
Politics
Sports
Culture
Crypto
Commodities
Climate
Economics
Mentions
Finance
Tech & Science
Predict
Live
78
Account
Search
Social
Medtronic (MDT) earnings | Kalshi
Medtronic
MDT
Earnings Call
Reports
Nov 17, 2026 · time not confirmed
Fiscal period
Not stated
Market cap
$110.38B
Consensus EPS
$1.34 · 7 estimates
Year-ago EPS
$1.36
Expected change
-1.5%
Quarterly markets
Q2 Cardiovascular Organic Revenue Growth
Open interest
4,816
Volume
14.3K
Trade
Q2 forecast from Kalshi traders
10.43%
-44.8% QoQ
Reported
Market implied
Other figures MDT reports
29 more reported metrics with no market on them yet
Acute Care & Monitoring Revenue
Cardiac Rhythm & Heart Failure Revenue
Cardiovascular Operating Profit
Cardiovascular Revenue
CardioVascular Surgery Revenue
Coronary & Peripheral Vascular Revenue
Cranial & Spinal Technologies Revenue
Diabetes Operating Profit
Diabetes Organic Revenue Growth
Diabetes Revenue
Emerging Markets Revenue
Interventional Cardiology Therapies Revenue
Medical Surgical Operating Profit
Medical Surgical Organic Revenue Growth
Medical Surgical Revenue
Neuromodulation Revenue
Neuroscience Operating Profit
Neuroscience Organic Revenue Growth
Neuroscience Revenue
Non-U.S. Developed Markets Revenue
Other Segment Operating Profit
Other Segment Revenue
Peripheral Vascular Health Revenue
Specialty Therapies Revenue
Structural Heart & Aortic Revenue
Surgical & Endoscopy Revenue
Total International Revenue
Total Organic Revenue Growth
U.S. Revenue
Acute Care & Monitoring Revenue
Cardiac Rhythm & Heart Failure Revenue
Cardiovascular Operating Profit
Cardiovascular Revenue
CardioVascular Surgery Revenue
Coronary & Peripheral Vascular Revenue
Cranial & Spinal Technologies Revenue
Diabetes Operating Profit
Diabetes Organic Revenue Growth
Diabetes Revenue
Emerging Markets Revenue
Interventional Cardiology Therapies Revenue
Medical Surgical Operating Profit
Medical Surgical Organic Revenue Growth
Medical Surgical Revenue
Neuromodulation Revenue
Neuroscience Operating Profit
Neuroscience Organic Revenue Growth
Neuroscience Revenue
Non-U.S. Developed Markets Revenue
Other Segment Operating Profit
Other Segment Revenue
Peripheral Vascular Health Revenue
Specialty Therapies Revenue
Structural Heart & Aortic Revenue
Surgical & Endoscopy Revenue
Total International Revenue
Total Organic Revenue Growth
U.S. Revenue
Q1 2027 reported
$539,000,000
-5.1% QoQ
No market on this figure
Q1 2027 reported
$539,000,000
-5.1% QoQ
Reported